David Hale F.'s Insider Trades & SAST Disclosures
David Hale F.'s most recent trade in Dermata Therapeutics Inc was a trade of 78,741 Warrant (Right to Buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Hale F..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dermata Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 78,741 | 78,741 | - | - | Warrant (Right to Buy) | |
| Dermata Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 78,741 | 80,957 | - | - | Common Stock | |
| Dermata Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 3,300 | 3,300 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | David Hale F. | Director | Purchase of securities on an exchange or from another person at price $ 9.04 per share. | 23 Feb 2024 | 714 | 714 (0%) | 0% | 9.0 | 6,455 | Common Stock |
| Oncternal Therapeutics Inc | David F. Hale | Director | Purchase of securities on an exchange or from another person at price $ 9.04 per share. | 23 Feb 2024 | 266 | 29,673 (0%) | 0% | 9.0 | 2,405 | Common Stock |
| Dermata Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 37,500 | 37,500 | - | - | Stock Options | |
| Dermata Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 26,441 | 45,565 | - | 0 | Common Stock | |
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 37,500 | 37,500 | - | - | Stock Options | |
| Dermata Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 15,466 | 19,124 | - | 0 | Common Stock | |
| Dermata Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 3,571,428 | 0 | - | - | Series 1c Preferred Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 555,622 | 0 | - | - | Series 1 Preferred Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 410,000 | 0 | - | - | Series 1b Preferred Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 302,112 | 0 | - | - | Series 1d Preferred Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 250,000 | 0 | - | - | Series 1a Preferred Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 174,216 | 505,822 | - | - | Common Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 62,500 | 0 | - | - | Series 1a Warrants | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 44,777 | 299,411 | - | - | Common Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Aug 2021 | 35,714 | 35,714 | - | - | Common Stock | |
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Aug 2021 | 35,714 | 35,714 | - | - | Warrant to Purchase Common Stock | |
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 27,103 | 532,925 | - | - | Common Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 20,000 | 331,606 | - | - | Common Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 12,195 | 311,606 | - | - | Common Stock | ||
| Dermata Therapeutics Inc | David F. Hale | Director, Ten Percent Owner | 17 Aug 2021 | 3,048 | 3,048 | - | - | Warrant to Purchase Common Stock | ||
| Biocept Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 37,500 | 37,500 | - | - | Stock Options | |
| Biocept Inc | David F. Hale | Director | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 12 Jun 2020 | 556 | 867 (0%) | 0% | 0.6 | 309 | Common Stock |
| Biocept Inc | David F. Hale | Director | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 12 Jun 2020 | 445 | 112 (0%) | 0% | 0.6 | 247 | Common Stock |
| Biocept Inc | David F. Hale | Director | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 12 Jun 2020 | 159 | 3,477 (0%) | 0% | 0.6 | 89 | Common Stock |
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 22,500 | 22,500 | - | - | Stock Option | |
| Biocept Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 500 | 500 | - | - | Employee Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | David F. Hale | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 May 2020 | 17,412 | 716,818 (4%) | 0% | - | Common Stock | |
| Oncternal Therapeutics Inc | David F. Hale | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 May 2020 | 8,706 | 8,706 | - | - | Warrants |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges